Search

everythinglearnresearchcommunity

for

Search:↓

Repigmentation in vitiligo may come from melanocyte stem cells in the skin.

Budesonide and N-acetylcysteine reduced tumors and alopecia in mice, regardless of FHIT gene status.

Consider benefits and risks of new alopecia treatments for safety.

Hormone therapy with estradiol and spironolactone can regrow scalp hair in transgender women by lowering testosterone to female levels.

Birth control pills help treat skin and hair growth problems linked to high male hormone levels.

A 78-year-old farmer with lung disease had skin lesions from a fungal infection that healed completely with medication.

Eclipta prostrata is a medicinal plant that helps treat diseases, protects the liver and nerves, and promotes hair growth.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

Hormonal therapies help treat female hair loss, but results are slow and vary.

Valproic acid and carbamazepine do not change biotin or biotinidase levels but may lower zinc levels, still within normal range.

JAK inhibitors may soon be a safe and effective treatment for alopecia areata.

Quick treatment of hair disorders in teenage girls is important because of the emotional effects.

Lupus panniculitis of the scalp causes linear hair loss and needs ongoing treatment to prevent recurrence and lupus.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Minoxidil and finasteride can slow or halt hair loss, but may have side effects.

Most treatments for hair loss in 1997 were not effective for most people, and maintaining hair growth was difficult.

Cyproterone acetate is effective for treating hirsutism, but some patients may feel worse on low-dose maintenance therapy.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

The document concludes that low-dose oral contraceptives and hormonal therapies can manage perimenopause symptoms and reduce some health risks, but lifestyle changes and disease screening are also important.

Primary care for PCOS focuses on lifestyle changes, medication based on symptoms, and mental health, with diabetes screening and specialist referral for severe cases.

Oral feline interferon-omega improved symptoms in diabetic cats with gingivostomatitis.

Children with HIV often have skin problems that can indicate the severity of their immune system damage.

Vitamin B12 deficiency can cause skin darkening and increased blood vessels, but treatment can improve symptoms.

The document suggests various treatments for PCOS, including medication for menstrual issues, insulin resistance, and excess hair, as well as fertility treatments, while highlighting the need for personalized care and lifestyle changes.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

Start acne treatment early to prevent scarring, consider antibiotic resistance, use maintenance therapy, and manage side effects carefully.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

Finasteride shows promise for treating hair loss and excessive hair growth, but more research is needed to confirm its effectiveness and safety.

Menopausal acne is treated with medications and lifestyle changes, but careful choice is needed due to side effects.